BB Biotech’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $297M | Buy |
3,366,786
+23,696
| +0.7% | +$2.09M | 7.46% | 3 |
|
|
2018
Q4 | $239M | Buy |
3,343,090
+185,000
| +6% | +$13.2M | 7.65% | 3 |
|
|
2018
Q3 | $388M | Sell |
3,158,090
-159,663
| -5% | -$19.6M | 10.28% | 2 |
|
|
2018
Q2 | $326M | Sell |
3,317,753
-85,000
| -2% | -$8.35M | 9.41% | 2 |
|
|
2018
Q1 | $282M | Sell |
3,402,753
-50,000
| -1% | -$4.15M | 7.8% | 4 |
|
|
2017
Q4 | $268M | Sell |
3,452,753
-10,000
| -0.3% | -$776K | 7.54% | 4 |
|
|
2017
Q3 | $212M | Buy |
3,462,753
+16,201
| +0.5% | +$993K | 5.87% | 6 |
|
|
2017
Q2 | $159M | Buy |
3,446,552
+245,000
| +8% | +$11.3M | 4.85% | 8 |
|
|
2017
Q1 | $139M | Buy |
3,201,552
+50,000
| +2% | +$2.16M | 4.53% | 9 |
|
|
2016
Q4 | $122M | Buy |
3,151,552
+30,000
| +1% | +$1.16M | 4.52% | 8 |
|
|
2016
Q3 | $158M | Hold |
3,121,552
| – | – | 5.56% | 6 |
|
|
2016
Q2 | $142M | Hold |
3,121,552
| – | – | 5.6% | 6 |
|
|
2016
Q1 | $123M | Hold |
3,121,552
| – | – | 4.91% | 7 |
|
|
2015
Q4 | $177M | Sell |
3,121,552
-50,000
| -2% | -$2.83M | 4.97% | 7 |
|
|
2015
Q3 | $126M | Sell |
3,171,552
-50,000
| -2% | -$1.99M | 4% | 9 |
|
|
2015
Q2 | $154M | Buy |
3,221,552
+20,000
| +0.6% | +$955K | 4.17% | 8 |
|
|
2015
Q1 | $127M | Buy |
3,201,552
+115,000
| +4% | +$4.57M | 3.79% | 9 |
|
|
2014
Q4 | $69M | Sell |
3,086,552
-30,000
| -1% | -$670K | 2.23% | 16 |
|
|
2014
Q3 | $48.8M | Buy |
3,116,552
+30,000
| +1% | +$470K | 1.99% | 16 |
|
|
2014
Q2 | $45.8M | Buy |
3,086,552
+90,000
| +3% | +$1.34M | 2.18% | 12 |
|
|
2014
Q1 | $48.2M | Buy |
2,996,552
+350,000
| +13% | +$5.63M | 2.49% | 13 |
|
|
2013
Q4 | $24.7M | Buy |
2,646,552
+696,404
| +36% | +$6.5M | 1.32% | 17 |
|
|
2013
Q3 | $22.1M | Buy |
+1,950,148
| New | +$22.1M | 1.2% | 20 |
|